254 related articles for article (PubMed ID: 18564497)
21. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments.
Aller E; Nájera C; Millán JM; Oltra JS; Pérez-Garrigues H; Vilela C; Navea A; Beneyto M
Eur J Hum Genet; 2004 May; 12(5):407-10. PubMed ID: 14970843
[TBL] [Abstract][Full Text] [Related]
22. Erratum: analysis of DNA elements that modulate myosin VIIa expression in humans.
Orten DJ; Weston MD; Kelley PM; Cremers CW; Wagenaar M; Jacobson SG; Kimberling WJ
Hum Mutat; 2000 Jan; 15(1):114-5. PubMed ID: 10612833
[TBL] [Abstract][Full Text] [Related]
23. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients.
Blanco-Kelly F; Jaijo T; Aller E; Avila-Fernandez A; López-Molina MI; Giménez A; García-Sandoval B; Millán JM; Ayuso C
JAMA Ophthalmol; 2015 Feb; 133(2):157-64. PubMed ID: 25375654
[TBL] [Abstract][Full Text] [Related]
24. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
Ebermann I; Scholl HP; Charbel Issa P; Becirovic E; Lamprecht J; Jurklies B; Millán JM; Aller E; Mitter D; Bolz H
Hum Genet; 2007 Apr; 121(2):203-11. PubMed ID: 17171570
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
[TBL] [Abstract][Full Text] [Related]
26. Two Finnish USH1B patients with three novel mutations in myosin VIIA.
Vastinsalo H; Isosomppi J; Aittakorpi A; Sankila EM
Mol Vis; 2006 Sep; 12():1093-7. PubMed ID: 17093394
[TBL] [Abstract][Full Text] [Related]
27. Genetic heterogeneity of Usher syndrome type II in a Dutch population.
Pieke-Dahl S; van Aarem A; Dobin A; Cremers CW; Kimberling WJ
J Med Genet; 1996 Sep; 33(9):753-7. PubMed ID: 8880575
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the myosin VIIA gene and visual function in patients with Usher syndrome type I.
Bharadwaj AK; Kasztejna JP; Huq S; Berson EL; Dryja TP
Exp Eye Res; 2000 Aug; 71(2):173-81. PubMed ID: 10930322
[TBL] [Abstract][Full Text] [Related]
29. Expressivity of hearing loss in cases with Usher syndrome type IIA.
Sadeghi AM; Cohn ES; Kimberling WJ; Halvarsson G; Möller C
Int J Audiol; 2013 Dec; 52(12):832-7. PubMed ID: 24160897
[TBL] [Abstract][Full Text] [Related]
30. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy.
Vaché C; Besnard T; le Berre P; García-García G; Baux D; Larrieu L; Abadie C; Blanchet C; Bolz HJ; Millan J; Hamel C; Malcolm S; Claustres M; Roux AF
Hum Mutat; 2012 Jan; 33(1):104-8. PubMed ID: 22009552
[TBL] [Abstract][Full Text] [Related]
31. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
32. Homozygosity mapping to the USH2A locus in two isolated populations.
Fagerheim T; Raeymaekers P; Merren J; Mani K; Jha GK; Baumbach L; Brox V; Breines E; Holdø BE; Holdø A; Tranebjaerg L
J Med Genet; 1999 Feb; 36(2):144-7. PubMed ID: 10051015
[TBL] [Abstract][Full Text] [Related]
33. Detection of a novel Cys628STOP mutation of the myosin VIIA gene in Usher syndrome type Ib.
Cuevas JM; Espinós C; Millán JM; Sánchez F; Trujillo MJ; García-Sandoval B; Ayuso C; Nájera C; Beneyto M
Mol Cell Probes; 1998 Dec; 12(6):417-20. PubMed ID: 9843659
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel locus for a USH3 like syndrome combined with congenital cataract.
Dad S; Østergaard E; Thykjaer T; Albrectsen A; Ravn K; Rosenberg T; Møller LB
Clin Genet; 2010 Oct; 78(4):388-97. PubMed ID: 20236115
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a.
Pennings RJ; Huygen PL; Orten DJ; Wagenaar M; van Aarem A; Kremer H; Kimberling WJ; Cremers CW; Deutman AF
Acta Ophthalmol Scand; 2004 Apr; 82(2):131-9. PubMed ID: 15043528
[TBL] [Abstract][Full Text] [Related]
36. Identification of candidate regions for a novel Usher syndrome type II locus.
Ben Rebeh I; Benzina Z; Dhouib H; Hadjamor I; Amyere M; Ayadi L; Turki K; Hammami B; Kmiha N; Kammoun H; Hakim B; Charfedine I; Vikkula M; Ghorbel A; Ayadi H; Masmoudi S
Mol Vis; 2008 Sep; 14():1719-26. PubMed ID: 18806881
[TBL] [Abstract][Full Text] [Related]
37. [From gene to disease; genetic causes of hearing loss and visual impairment sometimes accompanied by vestibular problems (Usher syndrome)].
Pennings RJ; Kremer H; Deutman AF; Kimberling WJ; Cremers CW
Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2354-8. PubMed ID: 12510399
[TBL] [Abstract][Full Text] [Related]
38. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.
Oishi M; Oishi A; Gotoh N; Ogino K; Higasa K; Iida K; Makiyama Y; Morooka S; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7369-75. PubMed ID: 25324289
[TBL] [Abstract][Full Text] [Related]
40. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
Kaiserman N; Obolensky A; Banin E; Sharon D
Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
